Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia

In the last decade, long-acting injectable antipsychotics has been widely used in schizophrenia. Aripiprazole long-acting once-monthly (AOM) is the only long-acting dopamine partial agonist antipsychotic approved for schizophrenia; however, a literature search revealed no guidance on safely switchin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chih-Sung, Su, Tung-Ping, Hsieh, Ming-Hsien, Lee, Chau-Shoun, Kuo, Joseph, Chiu, Nan-Ying, Chen, Po-See, Yen, Yung-Chieh, Bai, Ya-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621108/
https://www.ncbi.nlm.nih.gov/pubmed/34834550
http://dx.doi.org/10.3390/jpm11111198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621108/
https://www.ncbi.nlm.nih.gov/pubmed/34834550
http://dx.doi.org/10.3390/jpm11111198

Ejemplares similares